Announcement as per Regulation 30 for Appointment of Non-Executive Independent Director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has made two key board-level appointments effective November 28, 2025. Ms. Pooja Narendra Sanghavi (DIN: 11387388) has been appointed as an Additional Non-Executive Independent Director for a five-year term, pending shareholder approval. Separately, Ms. Vaishnavi Sahu has been appointed as the Company Secretary and Compliance Officer. Ms. Sanghavi brings extensive experience in corporate law, SEBI regulations, and compliance matters, while Ms. Sahu is an Associate Member of ICSI and a Commerce Graduate. Neither appointee is related to any existing director on the board.
These appointments strengthen the company's governance and compliance function, which is positive for corporate governance standards. Shareholders will need to approve the independent director's appointment at a general meeting.